Rigorous science done transparently

 

RESEARCH

The science of psychedelic microdosing

MICRODOSING PSILOCYBIN

Microdosing is more popular than ever, but we still don’t really understand how it works and what it does. There has been a recent groundswell of journalism on the topic, but there is almost no scientific evidence for the effects of this practice. We are preparing a study that will measure the empirical effects of microdosing. Our design will be a double-blind placebo-controlled crossover washout trial. We aim to have 100 participants in our first study.

publication

PUBLICATIONS

We have published some of the first academic research on psychedelic microdosing. Click on the publication link at the top of the page or on the document icon to the left to check them out. You can also scroll down to find media covering our research.

 

CONSULTING

Helping industry remain scientific and open

services
sponsor
 

OUR TEAM

 

ROTEM PETRANKER

Co-Founder and Director

Rotem is a Clinical Psychology PhD student with John Eastwood's lab at York University.  His main research interests are sustained attention, emotional regulation, and creativity, all of which are ostensibly affected by psychedelics. Rotem is passionate about establishing a rigorous framework for the study of psychedelics using the principles of Open Science. His clinical interests include disorders amenable to psychedelic psychotherapy, including mood disorders and OCD.

THOMAS ANDERSON

Co-Founder and Director

Thomas Anderson is a PhD Candidate studying Cognitive Neuroscience at the University of Toronto (Toronto, Canada). Thomas is a strong proponent of open science and publicly communicating scientific findings. He has shared our research findings and presentations on ResearchGate and keeps an active account on Reddit to communicate about this research with the public.

EMILY KULPA

Research Associate

Emily Kulpa, Pharm.D. is a licensed clinical pharmacist with a background in medication therapy management focused on optimizing therapeutic outcomes. She is the Director of Medical Health Screening at Synthesis, a legal, medically supervised, psilocybin retreat centre for professionals to experience personal growth, emotional breakthroughs, and spiritual development.

JOYA HALLS

Digital Content Coordinator

Joya Halls is Practice Manager of a naturopathic clinic in North York (Toronto, Canada). As a consultant and patient advocate, Joya is a firm believer in patient access to medical cannabis, ketamine and psychedelics. Her many years of experience in health care, addiction medicine and medical cannabis have inspired Joya to return to University with a focus of Psychology. Her goal is to become a Psychotherapist, helping patients heal themselves with the assistance of psychedelics. 

MEDIA

CONTACT US

SUBSCRIBE FOR UPDATES

 
  • LinkedIn

©2020 by Canadian Centre for Psychedelic Science Inc.